Related Experiment Video
Updated: Dec 14, 2025
04:22
Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
616
Erectile dysfunction and adherence to antihypertensive therapy: Focus on β-blockers
Athanasios Manolis1, Michael Doumas2, Claudio Ferri3
1Cardiology Department, Asklepeion Hospital, Athens, Greece.
European Journal of Internal Medicine
|July 23, 2020
Summary
Beta-blockers used for hypertension can cause erectile dysfunction, leading to poor treatment adherence. Nebivolol, a unique beta-blocker, may improve erectile function, offering a potential exception for better blood pressure management.
Area of Science:
- Cardiology
- Pharmacology
- Urology
Background:
- Arterial hypertension management is challenging, with low blood pressure control rates.
- Poor adherence to antihypertensive treatment is a major cause of inadequate blood pressure control.
- Medication adverse events are a primary reason for treatment discontinuation.
Purpose of the Study:
- To review the impact of beta-blockers on erectile function.
- To explore the potential benefits of nebivolol on erectile function in hypertensive patients.
Main Methods:
- Literature review of studies on beta-blockers and erectile dysfunction.
- Analysis of evidence regarding nebivolol's effect on nitric oxide bioavailability and erectile function.
Main Results:
- Beta-blockers are frequently associated with adverse events, including erectile dysfunction.
- Recent studies indicate a negative impact of beta-blockers on erectile function.
- Nebivolol's unique mechanism may improve erectile function, differentiating it from other beta-blockers.
Conclusions:
- Nebivolol may be an exception among beta-blockers regarding erectile function.
- This finding has implications for improving adherence and blood pressure control in hypertensive patients.
Related Concept Videos
01:17Antihypertensive Drugs: Action of β1 Blockers
1.8K
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
1.8K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
773
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
773
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
447
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
447
01:28Antihypertensive Drugs: Types of β-Blockers
1.3K
β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and...
1.3K
01:22Heart Failure Drugs: β-Blockers
649
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
649
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.1K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.1K